The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
IVD Infectious Disease-Global Market Insights and Sales Trends 2025
Synopsis
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global IVD Infectious Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVD Infectious Disease in various end use industries. The expanding demands from the Personal, Commercial, Academic and Other, are propelling IVD Infectious Disease market. Biochemical Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immune Diagnosis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVD Infectious Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVD Infectious Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVD Infectious Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVD Infectious Disease covered in this report include Roche Diagnostics, Abbott Laboratories, Abbott, Gen-Probe, Becton Dickinson (BD), Bio-Rad Laboratories, Siemens Healthcare, Biomérieux and Danaher, etc.
The global IVD Infectious Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Global IVD Infectious Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVD Infectious Disease market, Segment by Type:
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Global IVD Infectious Disease market, by Application
Personal
Commercial
Academic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVD Infectious Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global IVD Infectious Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVD Infectious Disease in various end use industries. The expanding demands from the Personal, Commercial, Academic and Other, are propelling IVD Infectious Disease market. Biochemical Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immune Diagnosis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVD Infectious Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVD Infectious Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVD Infectious Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVD Infectious Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVD Infectious Disease covered in this report include Roche Diagnostics, Abbott Laboratories, Abbott, Gen-Probe, Becton Dickinson (BD), Bio-Rad Laboratories, Siemens Healthcare, Biomérieux and Danaher, etc.
The global IVD Infectious Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Global IVD Infectious Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVD Infectious Disease market, Segment by Type:
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Global IVD Infectious Disease market, by Application
Personal
Commercial
Academic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVD Infectious Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of IVD Infectious Disease
1.1 IVD Infectious Disease Market Overview
1.1.1 IVD Infectious Disease Product Scope
1.1.2 IVD Infectious Disease Market Status and Outlook
1.2 Global IVD Infectious Disease Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global IVD Infectious Disease Market Size by Region (2018-2029)
1.4 Global IVD Infectious Disease Historic Market Size by Region (2018-2023)
1.5 Global IVD Infectious Disease Market Size Forecast by Region (2024-2029)
1.6 Key Regions, IVD Infectious Disease Market Size (2018-2029)
1.6.1 North America IVD Infectious Disease Market Size (2018-2029)
1.6.2 Europe IVD Infectious Disease Market Size (2018-2029)
1.6.3 Asia-Pacific IVD Infectious Disease Market Size (2018-2029)
1.6.4 Latin America IVD Infectious Disease Market Size (2018-2029)
1.6.5 Middle East & Africa IVD Infectious Disease Market Size (2018-2029)
2 IVD Infectious Disease Market by Type
2.1 Introduction
2.1.1 Biochemical Diagnosis
2.1.2 Immune Diagnosis
2.1.3 Molecular Diagnosis
2.1.4 Microbiological Diagnosis
2.1.5 Urine Diagnosis
2.1.6 Coagulation Diagnosis
2.1.7 Other
2.2 Global IVD Infectious Disease Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global IVD Infectious Disease Historic Market Size by Type (2018-2023)
2.2.2 Global IVD Infectious Disease Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America IVD Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.2 Europe IVD Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific IVD Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America IVD Infectious Disease Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa IVD Infectious Disease Revenue Breakdown by Type (2018-2029)
3 IVD Infectious Disease Market Overview by Application
3.1 Introduction
3.1.1 Personal
3.1.2 Commercial
3.1.3 Academic
3.1.4 Other
3.2 Global IVD Infectious Disease Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global IVD Infectious Disease Historic Market Size by Application (2018-2023)
3.2.2 Global IVD Infectious Disease Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America IVD Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.2 Europe IVD Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific IVD Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America IVD Infectious Disease Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa IVD Infectious Disease Revenue Breakdown by Application (2018-2029)
4 IVD Infectious Disease Competition Analysis by Players
4.1 Global IVD Infectious Disease Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2022)
4.3 Date of Key Players Enter into IVD Infectious Disease Market
4.4 Global Top Players IVD Infectious Disease Headquarters and Area Served
4.5 Key Players IVD Infectious Disease Product Solution and Service
4.6 Competitive Status
4.6.1 IVD Infectious Disease Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostics
5.1.1 Roche Diagnostics Profile
5.1.2 Roche Diagnostics Main Business
5.1.3 Roche Diagnostics IVD Infectious Disease Products, Services and Solutions
5.1.4 Roche Diagnostics IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostics Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories IVD Infectious Disease Products, Services and Solutions
5.2.4 Abbott Laboratories IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott IVD Infectious Disease Products, Services and Solutions
5.3.4 Abbott IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.3.5 Gen-Probe Recent Developments
5.4 Gen-Probe
5.4.1 Gen-Probe Profile
5.4.2 Gen-Probe Main Business
5.4.3 Gen-Probe IVD Infectious Disease Products, Services and Solutions
5.4.4 Gen-Probe IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.4.5 Gen-Probe Recent Developments
5.5 Becton Dickinson (BD)
5.5.1 Becton Dickinson (BD) Profile
5.5.2 Becton Dickinson (BD) Main Business
5.5.3 Becton Dickinson (BD) IVD Infectious Disease Products, Services and Solutions
5.5.4 Becton Dickinson (BD) IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.5.5 Becton Dickinson (BD) Recent Developments
5.6 Bio-Rad Laboratories
5.6.1 Bio-Rad Laboratories Profile
5.6.2 Bio-Rad Laboratories Main Business
5.6.3 Bio-Rad Laboratories IVD Infectious Disease Products, Services and Solutions
5.6.4 Bio-Rad Laboratories IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Rad Laboratories Recent Developments
5.7 Siemens Healthcare
5.7.1 Siemens Healthcare Profile
5.7.2 Siemens Healthcare Main Business
5.7.3 Siemens Healthcare IVD Infectious Disease Products, Services and Solutions
5.7.4 Siemens Healthcare IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.7.5 Siemens Healthcare Recent Developments
5.8 Biomérieux
5.8.1 Biomérieux Profile
5.8.2 Biomérieux Main Business
5.8.3 Biomérieux IVD Infectious Disease Products, Services and Solutions
5.8.4 Biomérieux IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.8.5 Biomérieux Recent Developments
5.9 Danaher
5.9.1 Danaher Profile
5.9.2 Danaher Main Business
5.9.3 Danaher IVD Infectious Disease Products, Services and Solutions
5.9.4 Danaher IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.9.5 Danaher Recent Developments
5.10 Thermo Fisher
5.10.1 Thermo Fisher Profile
5.10.2 Thermo Fisher Main Business
5.10.3 Thermo Fisher IVD Infectious Disease Products, Services and Solutions
5.10.4 Thermo Fisher IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.10.5 Thermo Fisher Recent Developments
5.11 Sysmex
5.11.1 Sysmex Profile
5.11.2 Sysmex Main Business
5.11.3 Sysmex IVD Infectious Disease Products, Services and Solutions
5.11.4 Sysmex IVD Infectious Disease Revenue (US$ Million) & (2018-2023)
5.11.5 Sysmex Recent Developments
6 North America
6.1 North America IVD Infectious Disease Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe IVD Infectious Disease Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Disease Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America IVD Infectious Disease Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Disease Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 IVD Infectious Disease Market Dynamics
11.1 IVD Infectious Disease Industry Trends
11.2 IVD Infectious Disease Market Drivers
11.3 IVD Infectious Disease Market Challenges
11.4 IVD Infectious Disease Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
